Reprint: Good laboratory practice: preventing introduction of bias at the bench.
As a research community, we have failed to show that drugs, which show substantial efficacy in animal models of cerebral ischemia, can also improve outcome in human stroke. Accumulating evidence suggests this may be due, at least in part, to problems in the design, conduct, and reporting of animal experiments which create a systematic bias resulting in the overstatement of neuroprotective efficacy. Here, we set out a series of measures to reduce bias in the design, conduct and reporting of animal experiments modeling human stroke.
Macleod
Malcolm R
MR
Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
Fisher
Marc
M
O'Collins
Victoria
V
Sena
Emily S
ES
Dirnagl
Ulrich
U
Bath
Philip M W
PM
Buchan
Alastair
A
Buchan
Alistair
A
van der Worp
H Bart
HB
Traystman
Richard J
RJ
Minematsu
Kazuo
K
Donnan
Geoffrey A
GA
Howells
David W
DW
D000818:Animals; D004195:Disease Models, Animal; D006801:Humans; D012107:Research Design; D020521:Stroke
Stroke. 2004 May;35(5):1216-24
15031455
Stroke. 2008 Oct;39(10):2824-9
18635842
Med J Aust. 2006 Sep 4;185(5):263-7
16948622
Ann Neurol. 2006 Mar;59(3):467-77
16453316
J Cereb Blood Flow Metab. 2006 Dec;26(12):1465-78
16525413
Trends Neurosci. 2007 Sep;30(9):433-9
17765332
JAMA. 1996 Aug 28;276(8):637-9
8773637
J Intern Med. 1995 Jan;237(1):89-94
7830036
Stroke. 2008 Mar;39(3):929-34
18239164
J Cereb Blood Flow Metab. 2005 Jun;25(6):713-21
15703698
Stroke. 1998 Oct;29(10):2203-10
9756604
Brain. 2007 Dec;130(Pt 12):3063-74
17478443
Ann Intern Med. 2001 Apr 17;134(8):663-94
11304107
Stroke. 1999 Dec;30(12):2752-8
10583007